Nobel Week Dialogue
In partnership with
Carl Bennet AB
Carl Bennet AB is an owner company, that through long-term and active ownership contributes to the development and value creation of its holdings. The company was founded in 1989 by Carl Bennet in connection with the acquisition of Getinge. Initially the company was only the main owner of Getinge AB (publ), but over the years developed its ownership to also include the listed companies Arjo AB (publ), Elanders AB (publ), and Lifco AB (publ). The Group also consist of the subsidiary Dragesholm AB. The Group operates globally through its companies in various industries with market-leading positions. Healthcare, medical technology, dental care, engineering and logistics are the main areas of activity. The number of employees in the Group amounts to approximately 33,000 in 50 countries.
Visit Carl Bennet AB’s website
City of Gothenburg
The City of Gothenburg is Sweden’s second-largest municipality, responsible for delivering public services and advancing urban development and sustainable growth through innovation and cross-sector collaboration.
Visit City of Gothenburg’s website
Royalty Pharma
Founded in 1996, Royalty Pharma (NASDAQ: RPRX) is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products.
Visit Royalty Pharma’s website
Volvo Group
Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions. Every day our customers use our products and services to transport, deliver, build, and ferry goods, objects and people around the world. Our products and services help to put food on our tables, carry people to work or school, build roads, keep our cities clean and much, much more, effectively helping to meet the growing demands of our world.
